CHF-6523

• UNSPSC Description:

  CHF-6523 is an orally active PI3Kδ inhibitor that can be used in research related to chronic obstructive pulmonary disease (COPD)[1].

• Target Antigen:

  PI3K

• Type:

  Reference compound

• Related Pathways:

  PI3K/Akt/mTOR

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/chf-6523.html

• Smiles:

  CN(CC1)CCN1CC2=CC(C(C3=CC=CC=C34)=C([C@H](C)N5C(N=CN=C6N)=C6C(C7=CN=CC(O)=C7)=N5)OC4=O)=CC=C2

• Molecular Weight:

  588.66

• References & Citations:

  [1]First-Time Drug Disclosures- 2024 EFMC-ISMC and ACS Fall

• Shipping Conditions:

  Room temperature

• Clinical Information:

  Phase 1

• CAS Number:

  2500579-21-3